224 related articles for article (PubMed ID: 19826422)
1. Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.
Huang HL; Yeh WC; Lai MZ; Mirtsos C; Chau H; Chou CH; Benchimol S
Br J Cancer; 2009 Nov; 101(9):1555-64. PubMed ID: 19826422
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
3. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts.
Vater CA; Bartle LM; Dionne CA; Littlewood TD; Goldmacher VS
Oncogene; 1996 Aug; 13(4):739-48. PubMed ID: 8761295
[TBL] [Abstract][Full Text] [Related]
5. Regulation of death complexes formation in tumor necrosis factor receptor signaling.
Chau H; Mirtsos C; Huang HL
Exp Cell Res; 2011 Aug; 317(13):1841-50. PubMed ID: 21621534
[TBL] [Abstract][Full Text] [Related]
6. E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S.
Perez D; White E
J Virol; 2003 Feb; 77(4):2651-62. PubMed ID: 12552004
[TBL] [Abstract][Full Text] [Related]
7. Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation.
Won M; Park KA; Byun HS; Sohn KC; Kim YR; Jeon J; Hong JH; Park J; Seok JH; Kim JM; Yoon WH; Jang IS; Shen HM; Liu ZG; Hur GM
Cell Death Differ; 2010 Dec; 17(12):1830-41. PubMed ID: 20448643
[TBL] [Abstract][Full Text] [Related]
8. In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.
Moujalled DM; Cook WD; Lluis JM; Khan NR; Ahmed AU; Callus BA; Vaux DL
Cell Death Differ; 2012 May; 19(5):808-15. PubMed ID: 22095280
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia.
Zhang Y; Ting AT; Marcu KB; Bliska JB
J Immunol; 2005 Jun; 174(12):7939-49. PubMed ID: 15944300
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
11. TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.
Lluis JM; Nachbur U; Cook WD; Gentle IE; Moujalled D; Moulin M; Wong WW; Khan N; Chau D; Callus BA; Vince JE; Silke J; Vaux DL
PLoS One; 2010 Jan; 5(1):e8620. PubMed ID: 20062539
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
15. Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro.
Geisler F; Algül H; Paxian S; Schmid RM
Gastroenterology; 2007 Jun; 132(7):2489-503. PubMed ID: 17570221
[TBL] [Abstract][Full Text] [Related]
16. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.
Mayo MW; Wang CY; Cogswell PC; Rogers-Graham KS; Lowe SW; Der CJ; Baldwin AS
Science; 1997 Dec; 278(5344):1812-5. PubMed ID: 9388187
[TBL] [Abstract][Full Text] [Related]
17. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
[TBL] [Abstract][Full Text] [Related]
18. A20 Inhibits β-Cell Apoptosis by Multiple Mechanisms and Predicts Residual β-Cell Function in Type 1 Diabetes.
Fukaya M; Brorsson CA; Meyerovich K; Catrysse L; Delaroche D; Vanzela EC; Ortis F; Beyaert R; Nielsen LB; Andersen ML; Mortensen HB; Pociot F; van Loo G; Størling J; Cardozo AK
Mol Endocrinol; 2016 Jan; 30(1):48-61. PubMed ID: 26652732
[TBL] [Abstract][Full Text] [Related]
19. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.
Klefstrom J; Arighi E; Littlewood T; Jäättelä M; Saksela E; Evan GI; Alitalo K
EMBO J; 1997 Dec; 16(24):7382-92. PubMed ID: 9405367
[TBL] [Abstract][Full Text] [Related]
20. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.
Kunter U; Daniel S; Arvelo MB; Choi J; Shukri T; Patel VI; Longo CR; Scali ST; Shrikhande G; Rocha E; Czismadia E; Mottley C; Grey ST; Floege J; Ferran C
Kidney Int; 2005 Oct; 68(4):1520-32. PubMed ID: 16164629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
